# Sibanye Stillwater Ltd: overview SBSW · NYSE · CIK 1786909 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/sbsw.md) · [Financials](/companies/sbsw/financials.md) · [Filings](/companies/sbsw/filings.md) · [Insiders](/companies/sbsw/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [127](/filings/0001786909-23-000034.md) | [172](/filings/0001786909-24-000019.md) | [138](/filings/0001786909-25-000021.md) | [114](/filings/0001786909-25-000021.md) | [112](/filings/0001786909-25-000021.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [23.0%](/filings/0001786909-23-000034.md) | [19.2%](/filings/0001786909-24-000019.md) | [13.3%](/filings/0001786909-25-000021.md) | [(33.2%)](/filings/0001786909-25-000021.md) | [(6.5%)](/filings/0001786909-25-000021.md) | | Diluted EPS | $ per share | [10.55](/filings/0001786909-23-000034.md) | [11.29](/filings/0001786909-24-000019.md) | [6.50](/filings/0001786909-25-000021.md) | [(13.34)](/filings/0001786909-25-000021.md) | [(2.58)](/filings/0001786909-25-000021.md) | | Free cash flow | $bn | [17.5](/filings/0001786909-23-000034.md) | [19.5](/filings/0001786909-24-000019.md) | [(0.4)](/filings/0001786909-25-000021.md) | [(15.3)](/filings/0001786909-25-000021.md) | [(11.5)](/filings/0001786909-25-000021.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sbsw/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Lingotto Investment Management LLP](/funds/1732768.md) | 2026-06-30 | $162.0m | 19,075,936 | | Reduced −500,000 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $61.8m | 7,273,849 | | Added +969,883 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $51.5m | 6,068,656 | | Reduced −2,834,471 | | [Bridgewater Associates, LP](/funds/1350694.md) | 2026-06-30 | $48.3m | 5,691,634 | | Added +1,265,183 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $45.6m | 5,369,975 | | Added +1,530,589 | | [Condire Management, LP](/funds/1847739.md) | 2026-06-30 | $44.5m | 5,244,469 | | Unchanged | | [Goehring & Rozencwajg Associates, LLC](/funds/1863154.md) | 2026-06-30 | $38.9m | 4,580,794 | | Added +310,725 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $38.9m | 4,576,952 | | Reduced −1,976,217 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $37.7m | 4,444,348 | | Reduced −612,304 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $34.8m | 4,097,087 | | Added +2,270,183 | ## Recent filings [All 428 filings](/companies/sbsw/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-14 | 11:14 ET | [6-K](/filings/0001205613-26-000073.md) | Report of a foreign private issuer, period 2026-10-14 | 0001205613-26-000073 | | 2026-10-07 | 06:11 ET | [6-K](/filings/0001205613-26-000072.md) | Report of a foreign private issuer, period 2026-10-07 | 0001205613-26-000072 | | 2026-09-30 | 11:48 ET | [6-K](/filings/0001205613-26-000071.md) | Report of a foreign private issuer, period 2026-09-30 | 0001205613-26-000071 | | 2026-09-29 | 09:05 ET | [6-K](/filings/0001205613-26-000067.md) | Report of a foreign private issuer, period 2026-09-29 | 0001205613-26-000067 | | 2026-09-28 | 11:19 ET | [6-K](/filings/0001205613-26-000066.md) | Report of a foreign private issuer, period 2026-09-28 | 0001205613-26-000066 | | 2026-09-18 | 11:49 ET | [6-K](/filings/0001205613-26-000065.md) | Report of a foreign private issuer, period 2026-09-18 | 0001205613-26-000065 | | 2026-09-15 | 06:52 ET | [6-K](/filings/0001205613-26-000063.md) | Report of a foreign private issuer, period 2026-09-15 | 0001205613-26-000063 | | 2026-09-08 | 07:13 ET | [6-K](/filings/0001205613-26-000060.md) | Report of a foreign private issuer, period 2026-09-08 | 0001205613-26-000060 | | 2026-09-08 | 06:30 ET | [6-K](/filings/0001205613-26-000059.md) | Report of a foreign private issuer, period 2026-09-08 | 0001205613-26-000059 | | 2026-09-02 | 12:45 ET | [6-K](/filings/0001205613-26-000058.md) | Report of a foreign private issuer, period 2026-09-02 | 0001205613-26-000058 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-026991.md), filed Apr 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1786909 - Tickers: SBSW, SBYSF - Exchange: NYSE - SIC code: 1040 Gold and Silver Ores - State of incorporation: T3 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:33 ET. No prices; not investment advice.